Self-assembly of Hg(ClO4)2 with
a pair of C
3-symmetric chiral ligands,
(1S,1′S,1″S,2R,2′R,2″R)-(benzenetricarbonyltris(azanediyl))tris(2,3-dihydro-1H-indene-2,1-diyl)trinicotinate
(s,r-L) and (1R,1′R,1″R,2S,2′S,2″S)-(benzenetricarbonyltris(azanediyl))tris(2,3-dihydro-1H-indene-2,1-diyl)trinicotinate
(r,s-L), produces a pair of chiral
cages C4H8O2@[(Hg2
II)3(ClO4)6(s,r-L)2(H2O)7](C4H8O2)7 and C4H8O2@[(Hg2
II)3(ClO4)6(r,s-L)2(H2O)7](C4H8O2)7, respectively, via straightforward formation
of the reduced Hg2
II species with an inner cavity
in which a single dioxane molecule is nestled. The pair of chiral
cages are transformed into their downsized pair of cages, [Hg3
II(ClO4)6(s,r-L)2] and [Hg3
II(ClO4)6(r,s-L)2], respectively, in the presence of hydrochloric acid.
The original chiral cages are more effective than the corresponding
downsized cages for enantiorecognition of chiral 3,4-dihydroxyphenylalanine
(DOPA) via the shifts of electrochemical oxidation potentials observed
by linear sweep voltammetry (LSV) technique. Furthermore, the photoluminescence
(PL) spectral shifts show that the downsized chiral cages significantly
recognize chiral DOPA.